Monitoring of Five Major Vital Signs: Blood Pressure, Pulse, Respiration, Body Temperature, and Oxygen Saturation
Personalized Patient Management Linked with Smart Bedside Monitoring System

Daewoong Pharmaceutical is introducing Korea's first cuffless blood pressure monitor capable of continuous 24-hour measurement into hospital settings and is beginning full-scale commercialization of a telemetry system that integratively manages patients' vital signs, including blood pressure, pulse, respiration, body temperature, and oxygen saturation.


On the 17th of last month, Lee Byunghwan, CEO of Skylabs, gave a presentation titled "The Era of Cuffless Blood Pressure Monitors" at the 62nd Spring Scientific Meeting of the Korean Society of Hypertension held at BEXCO in Busan. Daewoong Pharmaceutical

On the 17th of last month, Lee Byunghwan, CEO of Skylabs, gave a presentation titled "The Era of Cuffless Blood Pressure Monitors" at the 62nd Spring Scientific Meeting of the Korean Society of Hypertension held at BEXCO in Busan. Daewoong Pharmaceutical

View original image

On the 20th, Daewoong Pharmaceutical announced that it will officially launch "CART ON," an artificial intelligence (AI)-based ring-type blood pressure monitor that can be linked to its smart bedside monitoring system "thynC," in September.


The existing thynC system could only measure four vital signs: pulse, respiration, body temperature, and oxygen saturation. With the integration of CART ON, blood pressure can now also be monitored. As a result, thynC has evolved into the next-generation smart monitoring system that, for the first time in Korea, can integratively monitor all five major vital signs?blood pressure, pulse, respiration, body temperature, and oxygen saturation?in real time, 24 hours a day.


CART ON is a medical device that can be easily worn on the finger and is characterized by its ability to measure ambulatory blood pressure continuously without a cuff or any separate measuring equipment. In particular, it can precisely track patterns of major abnormal blood pressure conditions?such as nocturnal hypertension, morning hypertension, and non-dipping nighttime blood pressure?that are difficult to detect with conventional methods. This enables proactive responses to patient conditions and is expected to significantly improve both the accuracy of medical care and the efficiency of healthcare professionals' work.


Medical staff can automatically collect major vital signs, including blood pressure, without waking the patient. Since the system is linked to the hospital's electronic medical record (EMR) system, it frees staff from repetitive manual record-keeping, greatly enhancing work efficiency. Patients can also receive care in greater comfort without the inconvenience or sleep disturbance caused by a cuff, and caregivers can check the patient's status at any time through real-time monitoring.


Daewoong Pharmaceutical stated that, with the integration of CART ON and thynC, the company has taken a step closer to its goal of moving beyond diagnosis-focused medical devices toward data-driven, personalized patient management and the establishment of a digital therapeutic environment.



Lee Changjae, CEO of Daewoong Pharmaceutical, said, "By continuously measuring the vital signs of hospitalized patients through the integrated system of CART ON and thynC, we can move beyond single-point measurements to precisely understand the patient's condition over time, thereby realizing a data-driven clinical environment where treatment decisions can be made based on this information."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing